Evidence map›Paper›PMID 35326809›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Genomic Characterization of Clinical

Andrey Shelenkov, Yulia Mikhaylova, Lyudmila Petrova, Irina Gaidukova, Mikhail Zamyatin, Vasiliy Akimkin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andrey ShelenkovCentral Research Institute of Epidemiology, Novogireevskaya Str., 3a, 111123 Moscow, Russia.ORCID 0000-0002-7409-077X
Yulia MikhaylovaCentral Research Institute of Epidemiology, Novogireevskaya Str., 3a, 111123 Moscow, Russia.ORCID 0000-0002-5646-538X
Lyudmila PetrovaNational Medical and Surgical Center named after N.I. Pirogov, Nizhnyaya Pervomayskaya Str., 70, 105203 Moscow, Russia.
Irina GaidukovaNational Medical and Surgical Center named after N.I. Pirogov, Nizhnyaya Pervomayskaya Str., 70, 105203 Moscow, Russia.
Mikhail ZamyatinNational Medical and Surgical Center named after N.I. Pirogov, Nizhnyaya Pervomayskaya Str., 70, 105203 Moscow, Russia.ORCID 0000-0002-2072-7798
Vasiliy AkimkinCentral Research Institute of Epidemiology, Novogireevskaya Str., 3a, 111123 Moscow, Russia.

Funding

The Ministry of Education and Science of the Russian Federation 075-15-2019-1666
6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has already affected all realms of public healthcare and, in particular, has led to increasing use of various antibiotics to treat possible bacterial coinfections even in cases for which such infections were not confirmed clinically. This could lead to an increase in the fraction and severity of multidrug-resistant bacterial isolates in healthcare facilities, especially in intensive care units (ICU). However, detailed epidemiological investigations, possibly including whole genome sequencing (WGS), are required to confirm the increase in antibiotic resistance and changes, if any, in the population and clonal structures of bacterial pathogens. In this study, we performed a comprehensive genomic and phenotypic characterization of selected multidrug-resistant

Indexed as

Acinetobacter baumanniiantibiotic resistanceCOVID-19genomic epidemiologyhealthcare-associated infectionswhole genome sequencing

Identifiers

PMID35326809
PMCPMC8944674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.